References
- Adem S, Comakli V, Kuzu M, Demirdag R. (2014). Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes. J Biochem Mol Toxicol, 28:510–14
- Albayrak C, Albayrak D. (2015). Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: Is G6PD deficiency exclusively male disease? Pediatr Hematol Oncol, 32:85–91
- Arese P, Gallo V, Pantaleo A, Turrini F. (2012). Life and death of glucose-6-phosphate dehydrogenase (G6PD) deficient erythrocytes – Role of redox stress and band 3 modifications. Transfus Med Hemother, 39:328–34
- Au WY, Ngai CW, Chan WM, et al. (2011). Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency. Ann Hematol, 90:1237–8
- Benzie IFF, Strain JJ. (1996). The free reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’. The FRAP assay. Anal Biochem, 239:70–6
- Biagiotti E, Guidi L, Del Grande P, Ninfali P. (2003). Glucose-6-phosphate dehydrogenase expression associated with NADPH-dependent reaction in cerebellar neurons. Cerebellum, 2:178–83
- Burtis CA, Ashwood ER, David E. (2005). Tietz text book of clinical chemistry, biochemical aspects of hematology, method of determination of glucose 6 phosphate dehydrogenase. 3rd ed. New York: Elsevier Publications, 1642–54
- Carrell RW, Winterbourn CC, French JK. (1977). Haemoglobin – frustrated oxidase? Implications for red cell metabolism. Hemoglobin, 1:815–27
- Franco RS. (2012). Measurement of red cell lifespan and aging. Transfus Med Hemother, 39:302–7
- Ganea E, Harding JJ. (2006). Glutathione-related enzymes and the eye. Curr Eye Res, 31:1–11
- Harman D. (2006). Free radical theory of aging: An update: Increasing the functional life span. Ann N Y Acad Sci, 1067:10–21
- He MH, Zhang Y. (2012). Advanced glycation end products inhibit glucose-6-phosphate dehydrogenase activity and expression in human umbilical vein endothelial cells. Sheng Li Xue Bao, 64:646–50
- Ho HY, Cheng ML, Chiu DT. (2007). Glucose-6-phosphate dehydrogenase from oxidative stress to cellular functions and degenerative diseases. Redox Rep, 12:109–18
- Ho HY, Cheng ML, Lu FJ, et al. (2000). Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic Biol Med, 29:156–69
- Ho HY, Cheng ML, Chiu DT. (2014). Glucose-6-phosphate dehydrogenase – Beyond the realm of red cell biology. Free Radic Res, 48:1028–48
- Horton JD. (2002). Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem Soc Trans, 30:1091–5
- Kumar P, Maurya PK. (2013). L-cysteine efflux in erythrocytes as a function of human age: Correlation with reduced glutathione and total antioxidant potential. Rejuvenation Res, 16:179–84
- Kumar P, Maurya PK. (2014). Epigallocatechin-3-gallate protects erythrocyte Ca2+-ATPase and Na+/K+-ATPase against oxidative induced damage during aging in humans. Adv Pharm Bull, 4:443–7
- Kumar P, Chand S, Chandra P, Maurya PK. (2015). Influence of dietary capsaicin on redox status in red blood cells during human aging. Adv Pharm Bull, 5:583–6
- Labuschagne CF, Brenkman AB. (2013). Current methods in quantifying ROS and oxidative damage in Caenorhabditis elegans and other model organism of aging. Ageing Res Rev, 12:918–30
- Leopold JA, Cap A, Scribner AW, et al. (2001). Glucose 6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases nitric oxide bioavailability. FASEB J, 15:1771–3
- Leopold JA, Zhang YY, Scribner AA, et al. (2003). Glucose 6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol, 23:411–17
- Maha AA. (2009). Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes. Hematology, 14:38–45
- Marks PA. (1967). Glucose-6-phosphate dehydrogenase in mature erythrocytes. Am J Clin Pathol, 47:287–95
- Maurya PK, Kumar P, Siddiqui N, et al. (2010). Age associated changes in erythrocyte glutathione peroxidase activity: Correlation with total antioxidant potential. Indian J Biochem Biophys, 47:319–21
- Maurya PK, Noto C, Rizzo LB, et al. (2016). The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 65:134–44
- Maurya PK, Prakash S. (2011). Intracellular uptake of (−) epicatechin by human erythrocytes as a function of human age. Phytother Res, 25:944–6
- Maurya PK, Prakash S. (2013). Decreased activity of Ca++-ATPase and Na+/K+-ATPase during aging in humans. Appl Biochem Biotechnol, 170:131–7
- Maurya PK, Rizvi SI. (2009). Protective role of tea catechins on erythrocytes subjected to oxidative stress during human aging. Nat Prod Res, 23:1072–9
- Maurya PK, Rizvi SI. (2010). Age dependent changes in glutathione-S-transferase: Correlation with total antioxidant potential and red cell intracellular glutathione. Indian J Clin Biochem, 25:398–400
- Maurya PK. (2014). Animal biotechnology as a tool to understand and fight aging. Animal biotechnology: Models in discovery and translation. USA: Elsevier Inc., 177–91
- Maurya PK, Kumar P, Chandra P. (2015). Biomarkers of oxidative stress in erythrocytes as a function of human age. World J Methodol, 5:216–22
- Muller G, Morawietz H. (2009). NAD(P)H oxidase and endothelial dysfunction. Horm Metab Res, 41:152–8
- Munro AW, Girvan HM, McLean KJ. (2007). Cytochrome P450-redox partner fusion enzymes. Biochim Biophys Acta, 1770:345–59
- Noh HB, Chandra P, Moon JO, Shim YB. (2012). In vivo detection of glutathione disulfide and oxidative stress monitoring using a biosensor. Biomaterials, 33:2600–7
- Pandey KB, Mehdi MM, Maurya PK, Rizvi SI. (2009). Plasma protein oxidation and its correlation with antioxidant potential during human aging. Dis Markers, 29:31–6
- Pararasa C, Ikwuobe J, Shigdar S, et al. (2015). Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell. [Epub ahead of print]. doi:10.1111/acel.12416
- Peters AL, van Bruggen R, de Korte D, et al. (2015). Glucose-6-phosphate dehydrogenase activity decreases during storage of leukoreduced red blood cells. Transfusion. doi:10.1111/trf.13378.
- Pinna A, Solinas G, Masia C, et al. (2008). Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy. Invest Ophthalmol Vis Sci, 49:1328–32
- Pirisi L, Garcea R, Pascale R, et al. (1987). Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene. Toxicol Pathol, 15:115–19
- Raicevic S, Eventov-Friedman S, Bolevich S, et al. (2014). Correlation between oxidative stress and G6PD activity in neonatal jaundice. Mol Cell Biochem, 395:273–9
- Renzaho AM, Husser E, Polonsky M. (2014). Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells. Transfus Med Rev, 28:7–17
- Rizvi SI, Jha R, Maurya PK. (2006). Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res, 9:470–4
- Rizvi SI, Maurya PK. (2007a). Alterations in antioxidant enzymes during aging in humans. Mol Biotechnol, 27:58–61
- Rizvi SI, Maurya PK. (2007b). Markers of oxidative stress in erythrocytes during aging in humans. Ann N Y Acad Sci, 1100:373–82
- Scott MD, Zuo L, Lubin BH, Chiu DT. (1991). NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. Blood, 77:2059–64
- Tang HY, Ho HY, Wu PR, et al. (2015). Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal, 22:744–59
- Tietze F. (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem, 27:502–22
- Ulusu NN. (2015). Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis. Med Hypotheses, 85:219–23
- Verdugo LP, Calvanese TM, Rodríguez VD, Cárcamo CC. (2014). Glucose-6-phosphate dehydrogenase deficiency in children: A case report. Rev Chil Pediatr, 85:74–9
- Xu Y, Zhang Z, Hu J, et al. (2010). Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J, 24:609–16
- Yang HC, Chen TL, Wu YH, et al. (2013). Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans. Cell Death Dis, 4:e616
- Zinovkin RA, Romaschenko VP, Galkin II, et al. (2014). Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging (Albany NY), 6:661–74